HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harsh Rajvanshi Selected Research

N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)

11/2021Learnings from two independent malaria elimination demonstration projects in India.
9/2020Demonstration of indigenous malaria elimination through Track-Test-Treat-Track (T4) strategy in a Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harsh Rajvanshi Research Topics

Disease

7Malaria
11/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

3InsecticidesIBA
02/2021 - 01/2019
2N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA
11/2021 - 09/2020
1Chloroquine (Aralen)FDA LinkGeneric
02/2021
1artemisinin (artemisinine)IBA
02/2021
1PrimaquineFDA Link
02/2021
1Polyvinyl Chloride (PVC)IBA
01/2021
1Antimalarials (Antimalarial Agents)IBA
01/2019

Therapy/Procedure

1Therapeutics
02/2021